| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.05 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |